CORT logo

CORT EBIT

Annual EBIT:

$136.95M+$29.67M(+27.66%)
December 31, 2024

Summary

  • As of today, CORT annual earnings before interest & taxes is $136.95 million, with the most recent change of +$29.67 million (+27.66%) on December 31, 2024.
  • During the last 3 years, CORT annual EBIT has risen by +$12.47 million (+10.02%).
  • CORT annual EBIT is now at all-time high.

Performance

CORT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCORTincome statement metrics

Quarterly EBIT:

$10.22M-$16.46M(-61.69%)
September 30, 2025

Summary

  • As of today, CORT quarterly earnings before interest & taxes is $10.22 million, with the most recent change of -$16.46 million (-61.69%) on September 30, 2025.
  • Over the past year, CORT quarterly EBIT has dropped by -$36.38 million (-78.07%).
  • CORT quarterly EBIT is now -78.07% below its all-time high of $46.60 million, reached on September 30, 2024.

Performance

CORT Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCORTincome statement metrics

TTM EBIT:

$65.57M-$36.38M(-35.68%)
September 30, 2025

Summary

  • As of today, CORT TTM earnings before interest & taxes is $65.57 million, with the most recent change of -$36.38 million (-35.68%) on September 30, 2025.
  • Over the past year, CORT TTM EBIT has dropped by -$77.79 million (-54.26%).
  • CORT TTM EBIT is now -54.26% below its all-time high of $143.36 million, reached on September 30, 2024.

Performance

CORT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCORTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CORT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+27.7%-78.1%-54.3%
3Y3 Years+10.0%-68.0%-48.3%
5Y5 Years+22.7%-58.7%-50.6%

CORT EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+27.7%-78.1%+199.2%-54.3%at low
5Y5-Yearat high+27.7%-78.1%+199.2%-54.3%at low
All-TimeAll-Timeat high+430.0%-78.1%+179.5%-54.3%+251.1%

CORT EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$10.22M(-61.7%)
$65.57M(-35.7%)
Jun 2025
-
$26.68M(+680.9%)
$101.95M(-8.0%)
Mar 2025
-
$3.42M(-86.5%)
$110.87M(-19.0%)
Dec 2024
$136.95M(+27.7%)
$25.26M(-45.8%)
$136.95M(-4.5%)
Sep 2024
-
$46.60M(+30.9%)
$143.36M(+12.1%)
Jun 2024
-
$35.59M(+20.7%)
$127.94M(+4.9%)
Mar 2024
-
$29.50M(-6.9%)
$121.93M(+13.7%)
Dec 2023
$107.28M(-4.8%)
$31.67M(+1.6%)
$107.28M(+9.3%)
Sep 2023
-
$31.18M(+5.4%)
$98.11M(-0.8%)
Jun 2023
-
$29.58M(+99.2%)
$98.87M(-1.8%)
Mar 2023
-
$14.85M(-34.0%)
$100.72M(-10.6%)
Dec 2022
$112.63M(-9.5%)
$22.50M(-29.5%)
$112.63M(-11.2%)
Sep 2022
-
$31.93M(+1.6%)
$126.80M(-3.3%)
Jun 2022
-
$31.43M(+17.4%)
$131.10M(-0.4%)
Mar 2022
-
$26.77M(-27.0%)
$131.61M(+5.7%)
Dec 2021
$124.48M(-2.9%)
$36.66M(+1.2%)
$124.48M(+5.2%)
Sep 2021
-
$36.23M(+13.4%)
$118.32M(+10.8%)
Jun 2021
-
$31.94M(+62.7%)
$106.81M(-3.0%)
Mar 2021
-
$19.64M(-35.6%)
$110.13M(-14.1%)
Dec 2020
$128.20M(+14.9%)
$30.51M(+23.4%)
$128.20M(-3.4%)
Sep 2020
-
$24.72M(-29.9%)
$132.71M(-5.9%)
Jun 2020
-
$35.26M(-6.5%)
$140.99M(+8.2%)
Mar 2020
-
$37.71M(+7.7%)
$130.36M(+16.8%)
Dec 2019
$111.61M(+24.7%)
$35.02M(+6.1%)
$111.61M(+10.0%)
Sep 2019
-
$33.00M(+34.0%)
$101.49M(+11.0%)
Jun 2019
-
$24.63M(+29.9%)
$91.46M(+4.6%)
Mar 2019
-
$18.96M(-23.9%)
$87.46M(-2.3%)
Dec 2018
$89.50M(+69.3%)
$24.90M(+8.4%)
$89.50M(+3.7%)
Sep 2018
-
$22.97M(+11.3%)
$86.30M(+12.1%)
Jun 2018
-
$20.63M(-1.7%)
$76.95M(+11.3%)
Mar 2018
-
$21.00M(-3.2%)
$69.11M(+30.8%)
Dec 2017
$52.85M(+419.3%)
$21.70M(+59.3%)
$52.85M(+46.2%)
Sep 2017
-
$13.62M(+6.5%)
$36.16M(+41.2%)
Jun 2017
-
$12.79M(+169.9%)
$25.61M(+78.8%)
Mar 2017
-
$4.74M(-5.3%)
$14.33M(+40.8%)
Dec 2016
$10.18M(+395.6%)
$5.01M(+63.0%)
$10.18M(+96.8%)
Sep 2016
-
$3.07M(+103.7%)
$5.17M(+134.9%)
Jun 2016
-
$1.51M(+154.7%)
$2.20M(+566.5%)
Mar 2016
-
$592.00K(>+9900.0%)
-$472.00K(+90.7%)
Dec 2015
-$3.44M(+87.5%)
$0.00(-100.0%)
-$5.09M(+37.7%)
Sep 2015
-
$102.00K(+108.7%)
-$8.17M(+38.9%)
Jun 2015
-
-$1.17M(+71.1%)
-$13.38M(+28.8%)
Mar 2015
-
-$4.03M(-31.0%)
-$18.79M(+32.0%)
Dec 2014
-$27.62M
-$3.08M(+39.7%)
-$27.62M(+20.1%)
Sep 2014
-
-$5.10M(+22.5%)
-$34.57M(+11.8%)
Jun 2014
-
-$6.58M(+48.8%)
-$39.21M(+9.7%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$12.86M(-28.2%)
-$43.41M(-4.6%)
Dec 2013
-$41.50M(-14.4%)
-$10.03M(-3.0%)
-$41.50M(-0.1%)
Sep 2013
-
-$9.74M(+9.7%)
-$41.45M(-5.3%)
Jun 2013
-
-$10.78M(+1.5%)
-$39.38M(-8.8%)
Mar 2013
-
-$10.94M(-9.6%)
-$36.19M(+0.2%)
Dec 2012
-$36.27M(-12.2%)
-$9.98M(-30.1%)
-$36.27M(-0.1%)
Sep 2012
-
-$7.67M(-1.0%)
-$36.22M(-3.5%)
Jun 2012
-
-$7.59M(+31.2%)
-$34.99M(+3.5%)
Mar 2012
-
-$11.03M(-11.1%)
-$36.26M(-12.2%)
Dec 2011
-$32.33M(-24.6%)
-$9.93M(-54.2%)
-$32.33M(-7.0%)
Sep 2011
-
-$6.44M(+27.4%)
-$30.23M(+2.2%)
Jun 2011
-
-$8.87M(-25.0%)
-$30.89M(-8.5%)
Mar 2011
-
-$7.10M(+9.3%)
-$28.47M(-3.8%)
Dec 2010
-$25.94M(-28.1%)
-$7.82M(-10.1%)
-$27.44M(-10.7%)
Sep 2010
-
-$7.11M(-10.2%)
-$24.78M(-10.9%)
Jun 2010
-
-$6.45M(-6.3%)
-$22.34M(-7.5%)
Mar 2010
-
-$6.06M(-17.5%)
-$20.78M(-2.6%)
Dec 2009
-$20.25M(-2.8%)
-$5.16M(-10.6%)
-$20.25M(+4.0%)
Sep 2009
-
-$4.67M(+4.3%)
-$21.10M(+1.1%)
Jun 2009
-
-$4.88M(+11.8%)
-$21.34M(-0.9%)
Mar 2009
-
-$5.53M(+8.0%)
-$21.14M(-7.4%)
Dec 2008
-$19.69M(-60.8%)
-$6.02M(-22.7%)
-$19.69M(-8.8%)
Sep 2008
-
-$4.90M(-4.6%)
-$18.09M(-7.6%)
Jun 2008
-
-$4.69M(-14.8%)
-$16.81M(-22.7%)
Mar 2008
-
-$4.08M(+7.6%)
-$13.70M(-11.9%)
Dec 2007
-$12.24M(+52.1%)
-$4.42M(-22.2%)
-$12.24M(-3.6%)
Sep 2007
-
-$3.62M(-129.1%)
-$11.82M(+19.9%)
Jun 2007
-
-$1.58M(+39.9%)
-$14.75M(+30.5%)
Mar 2007
-
-$2.63M(+34.2%)
-$21.23M(+17.0%)
Dec 2006
-$25.58M(-20.9%)
-$3.99M(+39.1%)
-$25.58M(+5.6%)
Sep 2006
-
-$6.55M(+18.8%)
-$27.10M(-4.1%)
Jun 2006
-
-$8.06M(-15.5%)
-$26.03M(-16.5%)
Mar 2006
-
-$6.98M(-26.8%)
-$22.35M(-5.6%)
Dec 2005
-$21.16M(-31.9%)
-$5.50M(-0.4%)
-$21.16M(+0.1%)
Sep 2005
-
-$5.48M(-25.0%)
-$21.18M(-6.1%)
Jun 2005
-
-$4.39M(+24.2%)
-$19.95M(-3.6%)
Mar 2005
-
-$5.79M(-4.8%)
-$19.26M(-20.1%)
Dec 2004
-$16.05M(-60.9%)
-$5.52M(-29.7%)
-$16.04M(-13.8%)
Sep 2004
-
-$4.26M(-15.3%)
-$14.09M(-17.5%)
Jun 2004
-
-$3.69M(-43.8%)
-$12.00M(-6.9%)
Mar 2004
-
-$2.57M(+28.0%)
-$11.23M(+21.6%)
Dec 2003
-$9.97M(+47.0%)
-$3.57M(-65.2%)
-$14.32M(-33.2%)
Sep 2003
-
-$2.16M(+26.0%)
-$10.75M(-25.2%)
Jun 2003
-
-$2.92M(+48.4%)
-$8.59M(-51.6%)
Mar 2003
-
-$5.67M
-$5.67M
Dec 2002
-$18.80M(-134.8%)
-
-
Dec 2001
-$8.01M
-
-

FAQ

  • What is Corcept Therapeutics Incorporated annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated annual EBIT year-on-year change?
  • What is Corcept Therapeutics Incorporated quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated quarterly EBIT year-on-year change?
  • What is Corcept Therapeutics Incorporated TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated TTM EBIT year-on-year change?

What is Corcept Therapeutics Incorporated annual earnings before interest & taxes?

The current annual EBIT of CORT is $136.95M

What is the all-time high annual EBIT for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high annual earnings before interest & taxes is $136.95M

What is Corcept Therapeutics Incorporated annual EBIT year-on-year change?

Over the past year, CORT annual earnings before interest & taxes has changed by +$29.67M (+27.66%)

What is Corcept Therapeutics Incorporated quarterly earnings before interest & taxes?

The current quarterly EBIT of CORT is $10.22M

What is the all-time high quarterly EBIT for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high quarterly earnings before interest & taxes is $46.60M

What is Corcept Therapeutics Incorporated quarterly EBIT year-on-year change?

Over the past year, CORT quarterly earnings before interest & taxes has changed by -$36.38M (-78.07%)

What is Corcept Therapeutics Incorporated TTM earnings before interest & taxes?

The current TTM EBIT of CORT is $65.57M

What is the all-time high TTM EBIT for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high TTM earnings before interest & taxes is $143.36M

What is Corcept Therapeutics Incorporated TTM EBIT year-on-year change?

Over the past year, CORT TTM earnings before interest & taxes has changed by -$77.79M (-54.26%)
On this page